Skip to main content

Characterization of Nuclear Glutamate Dehydrogenase of Chicken Liver and Brain

Buy Article:

$63.00 plus tax (Refund Policy)

Glutamate dehydrogenase (GDH) enzyme is recently being reported to be present in the nucleus in addition to the mitochondria in a number of organisms. Here we investigated the distribution of GDH in liver and brain tissues of chicken. Polyclonal anti-GDH antibody against bovine GDH was raised by us, which was later shown to be immunereactive to chicken GDH. The nuclear and the mitochondrial extracts from liver and brain tissues of chicken were made as described. By quantitative immunoreactivity, it was revealed that the nuclear GDH expressed in comparable efficiencies in the liver and brain. However, the activity of the brain nuclear GDH was lower than the liver counterparts. The allosteric regulation pattern for the brain nuclear GDH was also different from the other corresponding fractions and it was speculated that the brain nuclear GDH was inactive. The liver and brain nuclear GDH were purified to homogeneity and comparison of specific activities of both the GDH ruled out the existence of any inhibitor in the brain nuclear GDH. It is hypothesized that the inactivation of the brain nuclear GDH in chicken could be due to some already known posttranslational modification. The present report throws light on the differential regulation pattern of GDH enzyme.





No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: ADP ribosyl transferase; CIAP; Electrophoresis; GDH inactivation; GLUD1; GTP; Glutamate dehydrogenase (GDH); Miyazaki; NAD(H); NADH controls; RT PCR; SDS-PAGE; cAMP-dependent; immunoreactivity; nuclear and mitochondrial extractsQ

Document Type: Research Article

Publication date: 2011-12-01

More about this publication?
  • Protein & Peptide Letters publishes short papers in all important aspects of protein and peptide research, including structural studies, recombinant expression, function, synthesis, enzymology, immunology, molecular modeling, drug design etc. Manuscripts must have a significant element of novelty, timeliness and urgency that merit rapid publication. Reports of crystallisation, and preliminary structure determinations of biologically important proteins are acceptable. Purely theoretical papers are also acceptable provided they provide new insight into the principles of protein/peptide structure and function.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more